Revelation Biosciences (REVB) vs VivoSim Labs (VIVS)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Revelation Biosciences is the larger company by market cap ($3.1 million vs $2.9 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | REVB | VIVS |
|---|---|---|
| Share price | $0.7739 | $0.1772 |
| Market cap | $3.08M | $2.94M |
| 1-day change | -6.55% | -7.47% |
| P/E ratio (TTM) | 0.17 | — |
| EPS (TTM) | $4.60 | $-4.47 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $6.24 | $3.41 |
| 52-week low | $0.75 | $0.17 |
| Distance from 52-week high | -87.60% | -94.80% |
| Analyst consensus | none | — |
| Avg. price target upside | +2193.58% | — |
| Average volume | 39.03K | 5.85M |
| Shares outstanding | 3.98M | 16.59M |
| Employees | 8 | 15 |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Biotechnology |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Revelation Biosciences
REVB stock →Revelation Biosciences, Inc. operates as a clinical-stage life science company that focuses on the rebalancing inflammation to optimize health.
Healthcare · Biotechnology · 8 employees
About VivoSim Labs
VIVS stock →VivoSim Labs, Inc., a pharmaceutical and biotechnology services company, provides testing of drugs and drug candidates in three-dimensional (3D) human tissue models of liver and intestine. It offers partners liver and intestinal toxicology insights through its new approach methodologies (NAM) models.
Healthcare · Biotechnology · 15 employees
REVB vs VIVS FAQ
Which is bigger, Revelation Biosciences or VivoSim Labs?
Revelation Biosciences (REVB) is larger, with a market capitalization of $3.08M compared with $2.94M for VivoSim Labs (VIVS).
Are Revelation Biosciences and VivoSim Labs in the same industry?
Yes. Both are classified in the Biotechnology industry within the Healthcare sector.